Uncovering the profile of somatic mtDNA mutations in Chinese Colorectal cancer patients

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Wang, Cheng Ye ^a   Li, Hui ^a   Hao, Xiao Dan ^a,d   Liu, Jia ^b   Wang, Jia Xin ^b   Wang, Wen Zhi ^a,d   Kong, Qing Peng ^a,c   Zhang, Ya Ping ^a,b,c  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b YUNNAN UNIVERSITY   (China)

^c KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CANCER PATIENT; CARCINOGENESIS; CHINESE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE FREQUENCY; GENE SEQUENCE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MITOCHONDRIAL GENOME; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; SOMATIC MUTATION; CLASSIFICATION; COLORECTAL TUMOR; GENETICS; MUTATION; PHYLOGENY;

COLORECTAL NEOPLASMS; DNA, MITOCHONDRIAL; HUMANS; MUTATION; PHYLOGENY;

EID: 79959592889     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021613     Document Type: Article

References (50)

1. Brandon M, Baldi P, Wallace DC, (2006) Mitochondrial mutations in cancer. Oncogene 25: 4647-4662.
2. Chatterjee A, Mambo E, Sidransky D, (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25: 4663-4674.
3. Warburg O, (1956) On the origin of cancer cells. Science 123: 309-314.
4. Chen JZ, Gokden N, Greene GF, Green B, Kadlubar FF, (2003) Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis 24: 1481-1487.
5. Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, et al. (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62: 200-207.
6. Beckman KB, Ames BN, (1997) Oxidative decay of DNA. J Biol Chem 272: 19633-19636.
7. Cadet J, Douki T, Gasparutto D, Ravanat JL, (2003) Oxidative damage to DNA: formation, measurement and biochemical features. Mutat Res 531: 5-23.
8. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102: 719-724.
9. Parr RL, Dakubo GD, Crandall KA, Maki J, Reguly B, et al. (2006) Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J Mol Diagn 8: 312-319.
10. Ohta S, (2006) Contribution of somatic mutations in the mitochondrial genome to the development of cancer and tolerance against anticancer drugs. Oncogene 25: 4768-4776.
11. Suissa S, Wang Z, Poole J, Wittkopp S, Feder J, et al. (2009) Ancient mtDNA genetic variants modulate mtDNA transcription and replication. PLoS Genet 5: e1000474.
12. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, et al. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320: 661-664.
13. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, et al. (2001) High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 28: 147-150.
14. Chinnery PF, Samuels DC, Elson J, Turnbull DM, (2002) Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? Lancet 360: 1323-1325.
15. Vega A, Salas A, Gamborino E, Sobrido MJ, Macaulay V, et al. (2004) mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene 23: 1314-1320.
16. Copeland WC, Wachsman JT, Johnson FM, Penta JS, (2002) Mitochondrial DNA alterations in cancer. Cancer Invest 20: 557-569.
17. Carew JS, Huang P, (2002) Mitochondrial defects in cancer. Mol Cancer 1: 9.
18. Salas A, Yao YG, Macaulay V, Vega A, Carracedo A, et al. (2005) A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2: e296.
19. Sun C, Kong QP, Palanichamy MG, Agrawal S, Bandelt HJ, et al. (2006) The dazzling array of basal branches in the mtDNA macrohaplogroup M from India as inferred from complete genomes. Mol Biol Evol 23: 683-690.
20. Kong QP, Yao YG, Sun C, Bandelt HJ, Zhu CL, et al. (2003) Phylogeny of east Asian mitochondrial DNA lineages inferred from complete sequences. Am J Hum Genet 73: 671-676.
21. Palanichamy MG, Sun C, Agrawal S, Bandelt HJ, Kong QP, et al. (2004) Phylogeny of mitochondrial DNA macrohaplogroup N in India, based on complete sequencing: implications for the peopling of South Asia. Am J Hum Genet 75: 966-978.
22. Wang CY, Wang HW, Yao YG, Kong QP, Zhang YP, (2007) Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer 121: 1253-1256.
23. Tan DJ, Bai RK, Wong LJ, (2002) Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62: 972-976.
24. Zhu W, Qin W, Bradley P, Wessel A, Puckett CL, et al. (2005) Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis 26: 145-152.
25. Sternberg D, Chatzoglou E, Laforet P, Fayet G, Jardel C, et al. (2001) Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain 124: 984-994.
26. Von Kleist-Retzow JC, Schauseil-Zipf U, Michalk DV, Kunz WS, (2003) Mitochondrial diseases-an expanding spectrum of disorders and affected genes. Exp Physiol 88: 155-166.
27. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, et al. (2010) Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 464: 610-614.
28. Mehrabi S, Akwe JA, Adams G Jr, Grizzle W, Yao X, et al. (2010) Analysis of mtDNA sequence variants in colorectal adenomatous polyps. Diagn Pathol 5: 66.
29. Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M, (2009) High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Dis Colon Rectum 52: 526-530.
30. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, et al. (2001) Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94: 429-431.
31. Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, et al. (2005) Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23: 3517-3525.
32. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, et al. (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20: 291-293.
33. Taylor RW, Barron MJ, Borthwick GM, Gospel A, Chinnery PF, et al. (2003) Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest 112: 1351-1360.
34. Santos C, Montiel R, Arruda A, Alvarez L, Aluja MP, et al. (2008) Mutation patterns of mtDNA: empirical inferences for the coding region. BMC Evol Biol 8: 167.
35. Santos C, Montiel R, Sierra B, Bettencourt C, Fernandez E, et al. (2005) Understanding differences between phylogenetic and pedigree-derived mtDNA mutation rate: a model using families from the Azores Islands (Portugal). Mol Biol Evol 22: 1490-1505.
36. Bendall KE, Macaulay VA, Baker JR, Sykes BC, (1996) Heteroplasmic point mutations in the human mtDNA control region. Am J Hum Genet 59: 1276-1287.
37. Greaves LC, Preston SL, Tadrous PJ, Taylor RW, Barron MJ, et al. (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci U S A 103: 714-719.
38. Osborne A, Reis AH, Bach L, Wangh LJ, (2009) Single-molecule LATE-PCR analysis of human mitochondrial genomic sequence variations. PLoS One 4: e5636.
39. White HE, Durston VJ, Seller A, Fratter C, Harvey JF, et al. (2005) Accurate detection and quantitation of heteroplasmic mitochondrial point mutations by pyrosequencing. Genet Test 9: 190-199.
40. Grzybowski T, (2000) Extremely high levels of human mitochondrial DNA heteroplasmy in single hair roots. Electrophoresis 21: 548-553.
41. Goodwin AC, Jadallah S, Toubaji A, Lecksell K, Hicks JL, et al. (2008) Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. Prostate 68: 766-772.
42. Babbar N, Casero RA Jr, (2006) Tumor necrosis factor-alpha increases reactive oxygen species by inducing spermine oxidase in human lung epithelial cells: a potential mechanism for inflammation-induced carcinogenesis. Cancer Res 66: 11125-11130.
43. Xu H, Chaturvedi R, Cheng Y, Bussiere FI, Asim M, et al. (2004) Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res 64: 8521-8525.
44. Sobin LHWC, eds. (2002) TNM classification of malignant tumors New York Wiley-Liss.
45. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147.
46. Kong QP, Bandelt HJ, Sun C, Yao YG, Salas A, et al. (2006) Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet 15: 2076-2086.
47. Bandelt HJ, Lahermo P, Richards M, Macaulay V, (2001) Detecting errors in mtDNA data by phylogenetic analysis. Int J Legal Med 115: 64-69.
48. Yao YG, Bravi CM, Bandelt HJ, (2004) A call for mtDNA data quality control in forensic science. Forensic Sci Int 141: 1-6.
49. Bandelt HJ, Yao YG, Salas A, Kivisild T, Bravi CM, (2007) High penetrance of sequencing errors and interpretative shortcomings in mtDNA sequence analysis of LHON patients. Biochem Biophys Res Commun 352: 283-291.
50. Kong QP, Salas A, Sun C, Fuku N, Tanaka M, et al. (2008) Distilling artificial recombinants from large sets of complete mtDNA genomes. PLoS One 3: e3016.